Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy

BACKGROUND/AIMS: Second-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma (PDAC) that progresses following gemcitabine-based treatment has not been established. This study aimed to investigate the efficacy and safety of second-line combination chemotherapy with capecitabin...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Gut Liver
Hoofdauteurs: Chung, Kwang Hyun, Ryu, Ji Kon, Son, Jun Hyuk, Lee, Jae Woo, Jang, Dong Kee, Lee, Sang Hyub, Kim, Yong-Tae
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Editorial Office of Gut and Liver 2017
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347656/
https://ncbi.nlm.nih.gov/pubmed/27965478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl16307
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items